Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07254884Not ApplicableNot Yet Recruiting

Safety and Efficacy of 2910 nm Fiber Laser Resurfacing and Laser-Coring

Role: lead

NCT07222397Not ApplicableRecruiting

2910 nm Erbium-Doped Fluoride Fiber Glass Laser for the Treatment of Advanced Perioral Lines and Wrinkles

Role: lead

NCT06317766Not ApplicableEnrolling By Invitation

Histological Study of the Effects of a 2910 nm Fiber Laser Technology

Role: lead

NCT05202834Completed

Evaluation of the UltraClear Laser Workstation for Skin Treatment - Histology Study of Laser Ablation on Human Skin

Role: lead

All 4 trials loaded